PATENT CLAIM ANALYSIS

Application Number: 16308690
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["546", "277700"]

Abstract:
The present invention concern a 2-oxo-1,2-dihydropyridine-3-carboxamide compound of Formula (I) in the treatment of pathologies which require a dual inhibitor of PDK1/AurA enzymes such as for instance tumours, particularly glioblastoma.

Claim (Index 21):
A method for treating a pathology requiring the use of a dual inhibitor of PDK1/AurA enzymes, said method comprising administering the 2-oxo-1,2-dihydropyridine-3-carboxamide compound of anyone of  claim 12  to a subject having said pathology.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 98.0
- Lexical Diversity: 1.09677
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15735468', '13855916', '13699547', '13148903', '13651312']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.786336577158082
- 35 USC 102 Novelty (BERT): 0.643202359980501
- Combined Prediction Score: 0.772023155440324
- Mean Citation Score: 396.819224
- Max Citation Score: 671.692
- Similarity Product: 574.1591492784022

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test